Business description: IXICO plc

IXICO plc is a United Kingdom-based medical imaging advanced analytics company. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Huntington's disease, Parkinson's disease and Alzheimer's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include the collection, analysis, management, and reporting on data generated in the course of a clinical study. Its data platforms include TrialTracker and Assessa. The TrialTracker platform provides a secure and compliant environment for the collection, analysis and interpretation of large image files and other data. Its neuroimaging biomarkers focus area includes Radiological Reads, Volumetric MRI, PET and SPECT, and Advanced MRI.

Number of employees: 81

Sales by Activity: IXICO plc

Fiscal Period: September20202021202220232024

Medical Labs & Research

9.53M 9.19M 8.64M 6.66M 5.77M
See all business segments

Geographical breakdown of sales: IXICO plc

Fiscal Period: September20202021202220232024

United States of America

1.99M 1.86M 2.71M 3.05M 2.36M

United Kingdom

6.37M 1.98M 2.06M 952K 1.33M

Netherlands

- 1.25M 436K 862K 742K

Ireland

- 482K 724K 689K 557K

Switzerland

- 3.25M 2.08M 816K 500K

Other - Europe

- 370K 638K 293K 272K

Europe

1.17M - - - -
See all geographic segments

Executive Committee: IXICO plc

Manager TitleAgeSince
Chief Executive Officer 51 2024-08-18
Director of Finance/CFO 48 2019-08-20
Chief Operating Officer - -
Chief Tech/Sci/R&D Officer - 2020-12-31
Chief Tech/Sci/R&D Officer 46 2011-12-31
See IXICO PLC governance

Composition of the Board of Directors: IXICO plc

Director TitleAgeSince
Chairman 49 -
Director/Board Member 48 2019-08-20
Director/Board Member 58 2022-01-20
Director/Board Member 61 2023-10-04
Composition of the Board of Directors

Shareholders: IXICO plc

NameEquities%Valuation
Octopus Investments Ltd.
18.18 %
16,850,400 18.18 % 3 M p
BGF Investment Management Ltd.
13.91 %
12,887,000 13.91 % 2 M p
Canaccord Genuity Asset Management Ltd.
8.062 %
7,471,000 8.062 % 1 M p
Canaccord Genuity Wealth Ltd.
5.054 %
4,683,071 5.054 % 698 293 p
Amati Global Investors Ltd. (Venture Capital)
5.015 %
4,647,697 5.015 % 693 018 p
List of IXICO PLC shareholders

Company details: IXICO plc

Ixico Plc

Griffin Court 15 Long Lane

EC1A 9PN, London

+44 20 3763 7499

http://www.ixico.com
address IXICO plc(IXI)

Other Biotechnology & Medical Research

Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
0.00%+2.13%+29.73%-76.70% 14.03M
-2.73%-3.27%+28.07%-4.63% 48.26B
-0.15%-6.68%-19.05%-14.67% 34.06B
-0.66%+0.73%+3.91%+23.44% 26.71B
+0.61%+7.87%+73.63%+86.50% 16.54B
+1.31%-1.15%-34.73%-17.96% 15.37B
-8.37%+19.88% - - 14.08B
+8.37%+12.17%-59.55%-75.57% 12.7B
-0.99%-6.62%-8.83%-34.41% 10.42B
+0.17%-3.88%-12.99%+139.54% 10.36B
Average +0.07%+1.58%+0.02%+2.84% 18.85B
Weighted average by Cap. -0.48%+0.54%+2.94%+6.79%
See all sector performances